Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
Background. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine sulfate (GS) in the treatment of osteoarthritis puts forward increased requirements for the safety of drugs, primarily in terms of effects on the liver and kidneys.Objective: systematization of data on t...
Saved in:
| Main Authors: | I. Yu. Torshin, A. M. Lila, O. A. Gromova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2022-01-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/630 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Russian experience with injectable chondroitin sulfate and glucosamine sulfate: a review of clinical trials
by: A. E. Karateev, et al.
Published: (2018-04-01) -
Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system
by: I. Yu. Torshin, et al.
Published: (2020-04-01) -
Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-04-01) -
Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome)
by: I. Yu. Torshin, et al.
Published: (2022-10-01) -
Efficacy of various regimens of bioactive marine fish concentrate, glucosamine sulfate, and chondroitin sulfate in treating knee osteoarthritis
by: D.G. Rekalov, et al.
Published: (2024-12-01)